4 unknown, 2 not yet recruiting, 1 completed. 6 Phase 3, 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 3, Not yet recruiting 2, Completed 1 |
| Phase 2 | 4 | Unknown 3, Completed 1 |
| Not applicable | 1 | Unknown 1 |
Follow Granulocyte Colony-Stimulating Factor(G-CSF): new trials by email Literature Review of Granulocyte Colony-Stimulating Factor(G-CSF) trials Research Report on Granulocyte Colony-Stimulating Factor(G-CSF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrauterine G-CSF Infusion for Thin Endometrium Granulocyte Colony-Stimulating Factor(G-CSF), Normal Saline - Thin Endometrium, Female Infertility | Phase 3 | Not yet recruiting | Nanjing University | 620 | 2026-10-01 | 2026-07-09 |
| Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML Mitoxantrone Hydrochloride Liposome, Cytarabine, Granulocyte Colony-Stimulating Factor(G-CSF) - Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | Phase 3 | Not yet recruiting | Ruijin Hospital | 168 | 2026-07-30 | 2026-07-29 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan (BU) - Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 232 | 2022-07-01 | 2022-07-08 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 242 | 2022-07-01 | 2023-03-21 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan (BU) - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 242 | 2021-01-15 | 2021-01-19 |
| The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia Dasatinib - Acute Myeloid Leukemia | Not applicable | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 132 | 2016-08-01 | 2022-08-03 |
| G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | Completed | Nanfang Hospital, Southern Medical University | 202 | 2016-04-18 | 2022-02-14 |
Myelodysplastic Syndromes (4) · Leukemia, Myeloid, Acute (2) · Infertility, Female (1)
Nanfang Hospital, Southern Medical University (4) · Institute of Hematology & Blood Diseases Hospital, China (1) · Nanjing University (1) · Ruijin Hospital (1)
China (5)
Qifa Liu (3) · Sujiang Zhang (1) · Yue Jiang (1) · Zhu Xiaofan (1)